Adar Poonawala

Premium

Finance

19 December, 2022

Poonawalla  to  target growth-stage firms with ₹1,000 cr fund

Adar Poonawalla, chief executive of Serum Institute of India, has sought regulatory approval to establish the Poonawalla Vision Fund to ......

Premium

Consumer

20 October, 2022

Wellness Forever to defer IPO on volatile market

Omni-channel retail pharmacy Wellness Forever Medicare Pvt. Ltd is set to follow on the footsteps of PharmEasy and delay plans ......